12,839
Views
63
CrossRef citations to date
0
Altmetric
Review

Global systematic review of primary immunodeficiency registries

ORCID Icon, , , ORCID Icon, , , , , , , , , , , , , , , , , , , , ORCID Icon, , , , , & show all
Pages 717-732 | Received 02 Jun 2020, Accepted 08 Jul 2020, Published online: 17 Sep 2020

References

  • Tangye SG, Al-Herz W, Bousfiha A, et al. Human inborn errors of immunity: 2019 update on the classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. 2020 Jan;40(1):24–64.
  • Seidel MG, Kindle G, Gathmann B, et al. The European Society for Immunodeficiencies (ESID) registry working definitions for the clinical diagnosis of inborn errors of immunity. J Allergy Clin Immunol Pract. 2019 Jul-Aug;7(6):1763–1770.
  • Kobrynski L, Powell RW, Bowen S. Prevalence and morbidity of primary immunodeficiency diseases, United States 2001-2007. J Clin Immunol. 2014 Nov;34(8):954–961.
  • Abolhassani H, Kiaee F, Tavakol M, et al. Fourth update on the Iranian National Registry of Primary Immunodeficiencies: integration of molecular diagnosis. J Clin Immunol. 2018 Oct;38(7):816–832.
  • Gathmann B, Grimbacher B, Beaute J, et al. The European internet-based patient and research database for primary immunodeficiencies: results 2006-2008. Clin Exp Immunol. 2009 Sep;157(Suppl 1):3–11.
  • Abolhassani H, Hammarstrom L, Cunningham-Rundles C. Current genetic landscape in common variable immune deficiency. Blood. 2020 Feb 27;135(9):656–667.
  • Abolhassani H, Aghamohammadi A, Fang M, et al. Clinical implications of systematic phenotyping and exome sequencing in patients with primary antibody deficiency. Genet Med. 2019 Jan;21(1):243–251.
  • Fasth A. Primary immunodeficiency disorders in Sweden: cases among children, 1974-1979. J Clin Immunol. 1982 Apr;2(2):86–92.
  • Baumgart KW, Britton WJ, Kemp A, et al. The spectrum of primary immunodeficiency disorders in Australia. J Allergy Clin Immunol. 1997 Sep;100(3):415–423.
  • Stray-Pedersen A, Abrahamsen TG, Froland SS. Primary immunodeficiency diseases in Norway. J Clin Immunol. 2000 Nov;20(6):477–485.
  • Eades-Perner AM, Gathmann B, Knerr V, et al. The European internet-based patient and research database for primary immunodeficiencies: results 2004-06. Clin Exp Immunol. 2007 Feb;147(2):306–312.
  • Kirkpatrick P, Riminton S. Primary immunodeficiency diseases in Australia and New Zealand. J Clin Immunol. 2007 Sep;27(5):517–524.
  • Lee WI, Huang JL, Jaing TH, et al. Distribution, clinical features and treatment in Taiwanese patients with symptomatic primary immunodeficiency diseases (PIDs) in a nationwide population-based study during 1985-2010. Immunobiology. 2011 Dec;216(12):1286–1294.
  • Ishimura M, Takada H, Doi T, et al. Nationwide survey of patients with primary immunodeficiency diseases in Japan. J Clin Immunol. 2011 Dec;31(6):968–976.
  • Hayakawa H, Iwata T, Yata J, et al. Primary immunodeficiency syndrome in Japan. I. Overview of a nationwide survey on primary immunodeficiency syndrome. J Clin Immunol. 1981 Jan;1(1):31–39.
  • Condino-Neto A, Sorensen RU, Gomez Raccio AC, et al. Current state and future perspectives of the Latin American Society for Immunodeficiencies (LASID). Allergol Immunopathol (Madr). 2015 Sep-Oct;43(5):493–497.
  • Modell V, Gee B, Lewis DB, et al. Global study of primary immunodeficiency diseases (PI)–diagnosis, treatment, and economic impact: an updated report from the Jeffrey Modell Foundation. Immunol Res. 2011 Oct;51(1):61–70.
  • Matamoros Flori N, Mila Llambi J, Espanol Boren T, et al. Primary immunodeficiency syndrome in Spain: first report of the National Registry in children and adults. J Clin Immunol. 1997 Jul;17(4):333–339.
  • Gathmann B, Mahlaoui N, Ceredih, et al. Clinical picture and treatment of 2212 patients with common variable immunodeficiency. J Allergy Clin Immunol. 2014 Jul;134(1):116–126.
  • Massaad MJ, Zainal M, Al-Herz W. Frequency and manifestations of autoimmunity among children registered in the Kuwait National Primary Immunodeficiency Registry. Front Immunol. 2020;11:1119.
  • Esser MJCA. Immunology C. Primary immunodeficiency-missed opportunities and treatment challenges. Curr Allergy Clin Immunol. 2012;25(4):184–188.
  • Cirillo E, Cancrini C, Azzari C, et al. Clinical, immunological, and molecular features of typical and atypical severe combined immunodeficiency: report of the Italian Primary Immunodeficiency Network. Front Immunol. 2019;10:1908.
  • Boton Pereira DH, Primo LS, Pelizari G, et al. Primary immunodeficiencies in a Mesoregion of Sao Paulo, Brazil: epidemiologic, clinical, and geospatial approach. Front Immunol. 2020;11:862.
  • [cited 2020 Jul 30].https://lasidregistry.org/view/statistics/general/2019-05
  • Aghamohammadi A, Moein M, Farhoudi A, et al. Primary immunodeficiency in Iran: first report of the National Registry of PID in children and adults. J Clin Immunol. 2002 Nov;22(6):375–380.
  • Aghamohammadi A, Mohammadinejad P, Abolhassani H, et al. Primary immunodeficiency disorders in Iran: update and new insights from the third report of the national registry. J Clin Immunol. 2014 May;34(4):478–490.
  • Wang LL, Jin YY, Hao YQ, et al. Distribution and clinical features of primary immunodeficiency diseases in Chinese children (2004-2009). J Clin Immunol. 2011 Jun;31(3):297–308.
  • Xia Y, He T, Luo Y, et al. Targeted next-generation sequencing for genetic diagnosis of 160 patients with primary immunodeficiency in south China. Pediatr Allergy Immunol. 2018 Dec;29(8):863–872.
  • Kilic SS, Ozel M, Hafizoglu D, et al. The prevalences [correction] and patient characteristics of primary immunodeficiency diseases in Turkey–two centers study. J Clin Immunol. 2013 Jan;33(1):74–83.
  • Cekic S, Metin A, Aytekin C, et al. The evaluation of malignancies in Turkish primary immunodeficiency patients; a multicenter study. Pediatr Allergy Immunol. 2020 Feb 14. PMID: 32060950. DOI:10.1111/pai.13231
  • Sanal O, Tezcan I. Thirty years of primary immunodeficiencies in Turkey. Ann N Y Acad Sci. 2011 Nov;1238:15–23.
  • Al-Saud B, Al-Mousa H, Al Gazlan S, et al. Primary immunodeficiency diseases in Saudi Arabia: a tertiary care hospital experience over a period of three years (2010-2013). J Clin Immunol. 2015 Oct;35(7):651–660.
  • Al-Mousa H, Abouelhoda M, Monies DM, et al. Unbiased targeted next-generation sequencing molecular approach for primary immunodeficiency diseases. J Allergy Clin Immunol. 2016 Jun;137(6):1780–1787.
  • Rhim JW, Kim KH, Kim DS, et al. Prevalence of primary immunodeficiency in Korea. J Korean Med Sci. 2012 Jul;27(7):788–793.
  • Jindal AK, Pilania RK, Rawat A, et al. Primary immunodeficiency disorders in India-A situational review. Front Immunol. 2017;8:714.
  • [cited 2020 Jul 30].http://ispid.org.in/
  • Bousfiha AA, Jeddane L, Ailal F, et al. Primary immunodeficiency diseases worldwide: more common than generally thought. J Clin Immunol. 2013 Jan;33(1):1–7.
  • Al-Herz W, Chou J, Delmonte OM, et al. Comprehensive genetic results for primary immunodeficiency disorders in a highly consanguineous population. Front Immunol. 2018;9:3146.
  • Al-Herz W, Al-Ahmed M, Al-Khabaz A, et al. The Kuwait National Primary Immunodeficiency Registry 2004-2018. Front Immunol. 2019;10:1754.
  • Ehlayel MS, Bener A, Laban MA. Primary immunodeficiency diseases in children: 15 year experience in a tertiary care medical center in Qatar. J Clin Immunol. 2013 Feb;33(2):317–324.
  • Lam DS, Lee TL, Chan KW, et al. Primary immunodeficiency in Hong Kong and the use of genetic analysis for diagnosis. Hong Kong Med J. 2005 Apr;11(2):90–96.
  • Lau Y. Asian network for molecular diagnosis of primary immunodeficiencies. BMC Proc. 2011;5(Suppl 1):O4.
  • Lee P, Lau Y-L. Chapter 55 - Considerations for primary immune deficiency disorders in Asia. In: Sullivan KE, Stiehm ER, editors. Stiehm’s immune deficiencies. Amsterdam: Academic Press; 2014. p. 965–976.
  • Al-Tamemi S, Naseem SU, Al-Siyabi N, et al. Primary immunodeficiency diseases in Oman: 10-year experience in a tertiary care hospital. J Clin Immunol. 2016 Nov;36(8):785–792.
  • Noh LM, Nasuruddin BA, Abdul Latiff AH, et al. Clinical-epidemiological pattern of primary immunodeficiencies in Malaysia 1987-2006: A 20 year experience in four Malaysian Hospitals. Med J Malaysia. 2013;68(1):13–17.
  • Benjasupattananan P, Simasathein T, Vichyanond P, et al. Clinical characteristics and outcomes of primary immunodeficiencies in Thai children: an 18-year experience from a tertiary care center. J Clin Immunol. 2009 May;29(3):357–364.
  • Habahbeh ZM, Abu-Shukair ME, Almutereen MA, et al. Primary antibody deficiencies at Queen Rania Children Hospital in Jordan: single center experience. IJI. 2014 Mar;11(1):49–58.
  • Lim DL, Thong BY, Ho SY, et al. Primary immunodeficiency diseases in Singapore–the last 11 years. Singapore Med J. 2003 Nov;44(11):579–586.
  • Bousfiha AA, Errami A, Jeddane L, et al. Primary Immunodeficiencies: epidemiology in the Maghreb. Tunis Med. 2018 Oct-Nov;96(10–11):672–677.
  • Sazzad HM, Rainey JJ, Mach O, et al. The feasibility of identifying children with primary immunodeficiency disorders: preparation for the polio post-eradication era in Bangladesh. Vaccine. 2012 Aug 3;30(36):5396–5400.
  • Eley BS, Hughes J, Cooper M, et al. Primary immunodeficiency diseases at Red Cross War Memorial Children’s Hospital. S Afr Med J. 1997 Dec;87(12):1684–1688.
  • Naidoo R, Ungerer L, Cooper M, et al. Primary immunodeficiencies: a 27-year review at a tertiary paediatric hospital in Cape Town, South Africa. J Clin Immunol. 2011;31(1):99–105. Febll.
  • Mellouli F, Mustapha IB, Khaled MB, et al. Report of the Tunisian Registry of primary immunodeficiencies: 25-years of experience (1988-2012). J Clin Immunol. 2015 Nov;35(8):745–753.
  • Reda SM, Afifi HM, Amine MM. Primary immunodeficiency diseases in Egyptian children: a single-center study. J Clin Immunol. 2009 May;29(3):343–351.
  • Galal N, Meshaal S, Elhawary R, et al. Patterns of primary immunodeficiency disorders among a highly consanguineous population: Cairo University Pediatric Hospital’s 5-year experience. J Clin Immunol. 2016 Oct;36(7):649–655.
  • Bousfiha AA, Jeddane L, El Hafidi N, et al. First report on the Moroccan registry of primary immunodeficiencies: 15 years of experience (1998-2012). J Clin Immunol. 2014 May;34(4):459–468.
  • Luzi G, Businco L, Aiuti F. Primary immunodeficiency syndromes in Italy: a report of the national register in children and adults. J Clin Immunol. 1983 Oct;3(4):316–320.
  • [cited 2020 Jul 30]. https://esid.org/Working-Parties/Registry-Working-Party/ESID-Database-Statistics
  • Pulvirenti F, Sangerardi M, Plebani A, et al. Health-related quality of life and emotional difficulties in chronic granulomatous disease: data on adult and pediatric patients from Italian Network for Primary Immunodeficiency (IPINet). J Clin Immunol. 2020;40(2):289–298.
  • Farruggia P, Fioredda F, Puccio G, et al. Idiopathic neutropenia of infancy: data from the Italian Neutropenia Registry. Am J Hematol. 2019;94(2):216–222.
  • group CTFPs. The French national registry of primary immunodeficiency diseases. Clin Immunol. 2010 May;135(2):264–272.
  • Mahlaoui N, Picard C, Bach P, et al. Genetic diagnosis of primary immunodeficiencies: a survey of the French National Registry. J Allergy Clin Immunol. 2019;143(4):1646–1649. e10.
  • Edgar JD, Buckland M, Guzman D, et al. The United Kingdom Primary Immune Deficiency (UKPID) Registry: report of the first 4 years’ activity 2008-2012. Clin Exp Immunol. 2014 Jan;175(1):68–78.
  • Shillitoe B, Bangs C, Guzman D, et al. The United Kingdom Primary Immune Deficiency (UKPID) registry 2012 to 2017. Clin Exp Immunol. 2018 Jun;192(3):284–291.
  • Thaventhiran JED, Lango Allen H, Burren OS, et al. Whole-genome sequencing of a sporadic primary immunodeficiency cohort. Nature. 2020 Jul;583(7814):90–95.
  • Abuzakouk M, Feighery C. Primary immunodeficiency disorders in the Republic of Ireland: first report of the national registry in children and adults. J Clin Immunol. 2005 Jan;25(1):73–77.
  • Pac M, Bernatowska E. Comprehensive activities to increase recognition of primary immunodeficiency and access to immunoglobulin replacement therapy in Poland. Eur J Pediatr. 2016 Aug;175(8):1099–1105.
  • El-Helou SM, Biegner A-K, Bode S, et al. The German National Registry of Primary Immunodeficiencies (2012-2017). Front Immunol. 2019;10:1272.
  • Gathmann B, Goldacker S, Klima M, et al. The German national registry for primary immunodeficiencies (PID). Clin Exp Immunol. 2013 Aug;173(2):372–380.
  • Bjorkander JF, Brodszki N, Carlsson Å, et al. Best possible treatment for all patients with Primary Immune Deficiency (PID) in Sweden regardless of social factors, sex, age or residence. J Allergy Clin Immunol. 2017 Feb 1;139(2, Supplement):AB249.
  • [cited 2020 Jul 30]. http://pidcare.se/
  • Ludviksson BR, Sigurdardottir ST, Johannsson JH, et al. Epidemiology of primary immunodeficiency in Iceland. J Clin Immunol. 2015 Jan;35(1):75–79.
  • Stray-Pedersen A, Sorte HS, Samarakoon P, et al. Primary immunodeficiency diseases: genomic approaches delineate heterogeneous Mendelian disorders. J Allergy Clin Immunol. 2017 Jan;139(1):232–245.
  • Westh L, Mogensen TH, Dalgaard LS, et al. Identification and characterization of a Nationwide Danish Adult Common Variable Immunodeficiency Cohort. Scand J Immunol. 2017 Jun;85(6):450–461.
  • Selenius JS, Martelius T, Pikkarainen S, et al. Unexpectedly high prevalence of common variable immunodeficiency in Finland. Front Immunol. 2017;8:1190.
  • Sediva A, Bataneant M, Belevtsev M, et al. Primary immunodeficiencies in Central and Eastern Europe-the power of networking report on the activity of the Jeffrey Modell Foundation Centers Network in Central and Eastern Europe. Immunol Res. 2019 Oct;67(4–5):358–367.
  • Boyle JM, Buckley RH. Population prevalence of diagnosed primary immunodeficiency diseases in the United States. J Clin Immunol. 2007 Sep;27(5):497–502.
  • Cooper MA, Pommering TL, Koranyi K. Primary immunodeficiencies. Am Fam Physician. 2003 Nov 15;68(10):2001–2008.
  • Zelazko M, Carneiro-Sampaio M, Cornejo de Luigi M, et al. Primary immunodeficiency diseases in Latin America: first report from eight countries participating in the LAGID. Latin American Group for Primary Immunodeficiency Diseases. J Clin Immunol. 1998 Mar;18(2):161–166.
  • Carneiro-Sampaio M. Chapter 53 - Considerations for primary immune deficiency disorders in South America. In: Sullivan KE, Stiehm ER, editors. Stiehm’s immune deficiencies. Amsterdam: Academic Press; 2014. p. 943–955.
  • Leiva LE, Zelazco M, Oleastro M, et al. Primary immunodeficiency diseases in Latin America: the second report of the LAGID registry. J Clin Immunol. 2007 Jan;27(1):101–108.
  • Wilson S, Ballas Z, Immunology C. Progression of specific antibody deficiency (SAD) to common variable immunodeficiency (CVID). J Allergy Clin Immunol. 2010;125(2):AB73.
  • Pedraza A, Vargas-Rumilla MI, Ramirez-Roa JL. [Registry of primary immunodeficiencies in children at a fourth level hospital. Bogota, 2010-2016]. Revista alergia Mexico. 2018 Oct-Dec;65(4):341–348.
  • Lugo Reyes SO, Ramirez-Vazquez G, Cruz Hernandez A, et al. Clinical features, non-infectious manifestations and survival analysis of 161 children with primary immunodeficiency in Mexico: a single center experience over two decades. J Clin Immunol. 2016 Jan;36(1):56–65.
  • Costa-Carvalho B, Gonzalez-Serrano M, Espinosa-Padilla S, et al. Latin American challenges with the diagnosis and treatment of primary immunodeficiency diseases. Expert Rev Clin Immunol. 2017 May;13(5):483–489.
  • Grumach AS, Duarte AJ, Bellinati-Pires R, et al. Brazilian report on primary immunodeficiencies in children: 166 cases studied over a follow-up time of 15 years. J Clin Immunol. 1997 Jul;17(4):340–345.
  • Carneiro-Sampaio M, Moraes-Vasconcelos D, Kokron CM, et al. Primary immunodeficiency diseases in different age groups: a report on 1,008 cases from a single Brazilian reference center. J Clin Immunol. 2013 May;33(4):716–724.
  • Modell V, Orange JS, Quinn J, et al. Global report on primary immunodeficiencies: 2018 update from the Jeffrey Modell Centers Network on disease classification, regional trends, treatment modalities, and physician reported outcomes. Immunol Res. 2018 Jun;66(3):367–380.
  • Pilania RK, Chaudhary H, Jindal AK, et al. Current status and prospects of primary immunodeficiency diseases in Asia. Genes Dis. 2020 Mar;7(1):3–11.
  • Bousfiha A, Jeddane L, Al-Herz W, et al. The 2015 IUIS phenotypic classification for primary immunodeficiencies. J Clin Immunol. 2015 Nov;35(8):727–738.
  • Aghamohammadi A, Abolhassani H, Mohammadinejad P, et al. The approach to children with recurrent infections. Iran J Allergy Asthma Immunol. 2012 Jun;11(2):89–109.
  • Al-Herz W, Zainal ME, Salama M, et al. Primary immunodeficiency disorders: survey of pediatricians in Kuwait. J Clin Immunol. 2008 Jul;28(4):379–383.
  • Rezaei N, Aghamohammadi A, Moin M, et al. Frequency and clinical manifestations of patients with primary immunodeficiency disorders in Iran: update from the Iranian Primary Immunodeficiency Registry. J Clin Immunol. 2006 Nov;26(6):519–532.
  • Moin M, Aghamohammadi A, Kouhi A, et al. Ataxia-telangiectasia in Iran: clinical and laboratory features of 104 patients. Pediatr Neurol. 2007 Jul;37(1):21–28.
  • Shabestari MS, Maljaei SH, Baradaran R, et al. Distribution of primary immunodeficiency diseases in the Turk ethnic group, living in the northwestern Iran. J Clin Immunol. 2007 Sep;27(5):510–516.
  • al-Attas RA, Rahi AH. Primary antibody deficiency in Arabs: first report from eastern Saudi Arabia. J Clin Immunol. 1998 Sep;18(5):368–371.
  • Gudmastad E. 2013 world population data sheet (PDF). Population Reference Bureau; 2013 [cited 2020 Jul 30]. Available from: www.prb.org
  • Erjaee A, Bagherpour M, Van Rooyen C, et al. Primary immunodeficiency in Africa - a review. S Afr Med J. 2019 Sep 10;109(8b):3–11.
  • Svensson T, Höglund M, Cherif H. Clinical significance of serum immunoglobulin G subclass deficiency in patients with chronic lymphocytic leukemia. Scand J Infect Dis. 2013;45(7):537–542.
  • [cited 2020 Jul 30].https://cci-reporting.uniklinik-freiburg.de/#/
  • Marschall K, Hoernes M, Bitzenhofer-Gruber M, et al. The Swiss National Registry for primary immunodeficiencies: report on the first 6 years’ activity from 2008 to 2014. Clin Exp Immunol. 2015 Oct;182(1):45–50.
  • Norio R. Finnish disease heritage I: characteristics, causes, background. Hum Genet. 2003 May;112(5–6):441–456.
  • Norio R. Finnish disease heritage II: population prehistory and genetic roots of Finns. Hum Genet. 2003 May;112(5–6):457–469.
  • [cited 2020 Jul 30]. https://gdpr-info.eu
  • Grimbacher B, Party ERW. The European Society for Immunodeficiencies (ESID) registry 2014. Clin Exp Immunol. 2014 Dec;178(Suppl 1):18–20.
  • Jonkman-Berk BM, van den Berg JM, Ten Berge IJ, et al. Primary immunodeficiencies in the Netherlands: national patient data demonstrate the increased risk of malignancy. Clin Immunol. 2015 Feb;156(2):154–162.
  • Gathmann B, Binder N, Ehl S, et al. The European internet-based patient and research database for primary immunodeficiencies: update 2011. Clin Exp Immunol. 2012 Mar;167(3):479–491.
  • Abdou NI, Greenwell CA, Mehta R, et al. Efficacy of intravenous gammaglobulin for immunoglobulin G subclass and/or antibody deficiency in adults. Int Arch Allergy Immunol. 2009;149(3):267–274.
  • Pyhtila BM, Shaw KA, Neumann SE, et al. Newborn screening for galactosemia in the United States: looking back, looking around, and looking ahead. JIMD Rep. 2015;15:79–93.
  • Rubin Z, Pappalardo A, Schwartz A, et al. Prevalence and outcomes of primary immunodeficiency in hospitalized children in the United States. J Allergy Clin Immunol Pract. 2018 Sep - Oct;6(5):1705–1710e1.
  • Joshi AY, Iyer VN, Hagan JB, et al. Incidence and temporal trends of primary immunodeficiency: a population-based cohort study. Mayo Clin Proc. 2009;84(1):16–22.
  • Chapel H, Prevot J, Gaspar HB, et al. Primary immune deficiencies - principles of care. Front Immunol. 2014;5:627.
  • Hernandez-Trujillo HS, Chapel H, Lo Re V 3rd, et al. Comparison of American and European practices in the management of patients with primary immunodeficiencies. Clin Exp Immunol. 2012 Jul;169(1):57–69.
  • de Vries E. European Society for Immunodeficiencies m. Patient-centred screening for primary immunodeficiency, a multi-stage diagnostic protocol designed for non-immunologists: 2011 update. Clin Exp Immunol. 2012 Jan;167(1):108–119.
  • Aghamohammadi A, Abolhassani H, Kutukculer N, et al. Patients with primary immunodeficiencies are a reservoir of poliovirus and a risk to polio eradication. Front Immunol. 2017;8:685.
  • Dias ALA, da Silva RG, Cunha FGP, et al. Managing costs in primary immunodeficiency: minimal immunophenotyping and three national references. APMIS. 2019 Apr;127(4):228–235.
  • Bener A, Mohammad RR. Global distribution of consanguinity and their impact on complex diseases: genetic disorders from an endogamous population. Egypt J Med Human Genet. 2017 Oct 1;18(4):315–320.
  • Aghamohammadi A, Montazeri A, Abolhassani H, et al. Health-related quality of life in primary antibody deficiency. Iran J Allergy Asthma Immunol. 2011 Mar;10(1):47–51.
  • Papa R, Cant A, Klein C, et al. Towards European harmonisation of healthcare for patients with rare immune disorders: outcome from the ERN RITA registries survey. Orphanet J Rare Dis. 2020 Jan 30;15(1):33.